Co-chairs

I, Bella Maranion, residing in United States of America, a Co-chair of the Technology and Economic Assessment Panel (TEAP), and Co-chair of TEAP task force on decision XXXIV/2 (Replenishment) declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a full-time employee of the United States Environmental Protection Agency’s (USEPA) Stratospheric Protection Division, Washington, DC. My responsibilities include working as Senior Advisor to the division which supports the U.S. transition away from ozone-depleting substances (ODS) and hydrofluorocarbons (HFCs). In this capacity, I work within the various sectors of use to support the review of the human health and environmental effects of alternatives and their adoption and programs to reduce emissions and ensure responsible management of stocks. I also work on issues such as recovery/recycling and destruction of ODS with related government and nongovernmental organizations and stakeholders in the U.S. The USEPA has an interest in the topics of the Montreal Protocol because the Agency is responsible for implementing national regulations and policies to meet the US commitments under the Protocol. In addition, the USEPA has funded government and non- governmental organizations working on ozone layer and climate protection, atmospheric science, and environmental and health effects research.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am not currently employed, consulting, or hold any other position in any entity which has an interest in the subject matter of TEAP or the task force. task force.
   • Government advice and other policy development: My responsibilities at the USEPA may include providing information and advice to stakeholders on the interpretation and compliance with national regulations to protect the ozone layer and climate related to the transition to alternatives in the U.S. I do not provide advice on significant issues to a government with respect to its implementation of the Montreal Protocol or engage in the development of significant policy positions of a government for a Montreal Protocol meeting.
   • Paid research activities, fellowships or grants: I am not performing any paid research activities or receive any fellowships or grants for work related to a proposed use of an ODS or HFCs or an alternative to a proposed use of an ODS or HFCs.
   • Other interests: I do not have other interests related to the subject matter of the TEAP or the task force.
5. The source of funding for my participation in the work of TEAP is USEPA.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2023 after I have signed it.

Signed: Bella Maranion
Date: 2023-02-09

I, Marta Pizano, residing in Colombia, a Co-chair of the Technology and Economic Assessment Panel (TEAP), Co-chair of MBTOC, and Member of TEAP Decision XXXIV/2 Replenishment Task Force till 31st December 2023 declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am an independent consultant often working for the Montreal Protocol Implementing Agencies involved with methyl bromide users and other key stakeholders in many countries, to identify and implement alternatives to methyl bromide, including research on QPS uses and their alternatives. I also consult for the agencies on other topics related to ODS and the Montreal Protocol, for example the sustainability of the phase-out achieved for different ODS, clarification on exempted uses, communication materials to raise awareness on various issues relating to the Protocol, SDGs and gender mainstreaming as they relate to the Montreal Protocol and others. I have worked for the United Nations Industrial Development Organization (UNIDO), the United Nations Development Programme (UNDP), the United Nations Environment Programme (UNEP) and its OzonAction Programme and the World Bank (WB). I have also assisted the Montreal Protocol Multilateral Fund (MLF) with monitoring and evaluation work. These assignements are conducted on a short-term basis, as an external consultant.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: as stated above I provide consultancy to implementing agencies and the MLF as an independent expert, on a variety of issues related to the Montreal Protocol.
   • Government advice and other policy development: (if answer is yes describe briefly) NO
   • Paid research activities, fellowships or grants: (if answer is yes describe briefly)
   • Other interests: (if answer is yes describe briefly)
5. As an A5 member my travel and accommodation to attend Montreal Protocol, TEAP and MBTOC meetings are funded by UNEP’s Ozone Secretariat. In addition, as co-chair of the TEAP and MBTOC, I receive some funding support from the Ozone Secretariat for administrative tasks related to the work of the TEAP and MBTOC. As a consultant who is self-employed, I conduct other work related to the Panel and MBTOC on a voluntary (unpaid) basis.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2023 after I have signed it.

Signed: Marta Pizano

Date: 2023-01-17

I, Ashley Woodcock, residing in United Kingdom, a Co-chair of the Technology and Economic Assessment Panel (TEAP) till 31st December 2023 declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Professor of Respiratory Medicine at University of Manchester UK and a Consultant Physician at the Manchester University NHS Foundation Trust.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I am Chairman of the Medicines Evaluation Unit (Clinical Trials), Axalbion , (Cough Treatment) and Reacta Healthcare (Allergy Diagnosis), none of which have any proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I have acted as a consultant for GlaxoSmithKline. I have presented on green inhalers at symposia for Novartis and Orion
   • Government advice and other policy development: NONE RELEVANT
   • Paid research activities, fellowships or grants: NONE RELEVANT
   • Other interests: NONE RELEVANT
5. The source of funding for my travel/accomodation to participate in the work of TEAP is my University and Hospital, and the United Kingdom Government (DEFRA)
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2023 after I have signed it.

Signed:Ashley Woodcock
Date: 2023-01-18